Parvovirus B19 infection in pregnancy studied by maternal viral load and immune responses

Fetal Diagnosis and Therapy

Volumn 22, Issue 1, 2006, Pages 55-62

  De Haan, Timo R ^a   Beersma, Matthias F C ^a   Claas, Eric C J ^a   Oepkes, Dick ^a   Kroes, Aloys C M ^a   Walther, Frans J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Early diagnosis; Hydrops fetalis; Immunoglobulin; Parvovirus B19; Viral load

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS DNA;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CASE REPORT; COURSE EVALUATION; EARLY DIAGNOSIS; ERYTHEMA INFECTIOSUM; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INTRAUTERINE INFECTION; MATERNAL SERUM; MEASUREMENT; PARVOVIRUS; PREGNANT WOMAN; PRIORITY JOURNAL; UNIVERSITY HOSPITAL; VERTICAL TRANSMISSION; VIRUS LOAD;

ADULT; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; FEMALE; FETAL BLOOD; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRAL LOAD;

EID: 33845764286     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095845     Document Type: Article

References (32)

1. Anderson MJ, Pattison JR: The human parvovirus. Brief review. Arch Virol 1984;82:137-148.
2. Corcoran A, Doyle S: Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol 2004;53:459-475.
3. Young NS, Brown KE: Parvovirus B19. N Engl J Med 2004;350:586-597.
4. Yaegashi N, Niinuma T, Chisaka H, Watanabe T, Uehara S, Okamura K, Moffatt S, Sugamura K, Yajima A: The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis. J Infect 1998;37:28-35.
5. Enders M, Weidner A, Zoellner I, Searle K, Enders G: Fetal morbidity and mortality after acute human parvovirus b19 infection in pregnancy: prospective evaluation of 1,018 cases. Prenat Diagn 2004;24:513-518.
6. Norbeck O, Papadogiannakis N, Petersson K, Hirbod T, Broliden K, Tolfvenstam T: Revised clinical presentation of parvovirus B19-associated intrauterine fetal death. Clin Infect Dis 2002;35:1032-1038.
7. von Kaisenberg CS, Jonat W: Fetal parvovirus B19 infection. Ultrasound Obstet Gynecol 2001;18:280-288.
8. van Kamp IL, Klumper FJ, Bakkum RS, Oepkes D, Meerman RH, Scherjon SA, Kanhai HH: The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. Am J Obstet Gynecol 2001;185:668-673.
9. Chisaka H, Morita E, Murata K, Ishii N, Yaegashi N, Okamura K, Sugamura K: A transgenic mouse model for non-immune hydrops fetalis induced by the NS1 gene of human parvovirus B19. J Gen Virol 2002;83:273-281.
10. Jordan JA, DeLoia JA: Globoside expression within the human placenta. Placenta 1999;20:103-108.
11. Searle K, Guilliard C, Wallat S, Schalasta G, Enders G: Acute parvovirus B19 infection in pregnant women - an analysis of serial samples by serological and semi-quantitative PCR techniques. Infection 1998;26:139-143.
12. Schalasta G, Schmid M, Lachmund T, Enders G: Lightcycler consensus PCR for rapid and differential detection of human erythrovirus B19 and V9 isolates. J Med Virol 2004;73:54-59.
13. Dieck D, Schild RL, Hansmann M, Eis-Hubinger AM: Prenatal diagnosis of congenital parvovirus B19 infection: value of serological and PCR techniques in maternal and fetal serum. Prenat Diagn 1999;19:1119-1123.
14. de Krijger RR, Elsacker-Niele AM, Mulder-Stapel A, Salimans MM, Dreef E, Weiland HT, van Krieken JH, Vermeij-Keers C: Detection of parvovirus B19 infection in first and second trimester fetal loss. Pediatr Pathol Lab Med 1998;18:23-34.
15. Hoebe CJ, Claas EC, Steenbergen JE, Kroes AC: Confirmation of an outbreak of parvovirus B19 in a primary school using IgM ELISA and PCR on thumb prick blood samples. J Clin Virol 2002;25:303-307.
16. Hokynar K, Norja P, Laitinen H, Palomaki P, Garbarg-Chenon A, Ranki A, Hedman K, Soderlund-Venermo M: Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests. J Clin Microbiol 2004;42:2013-2019.
17. Knoll A, Louwen F, Kochanowski B, Plentz A, Stussel J, Beckenlehner K, Jilg W, Modrow S: Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (Taq-Man PCR). J Med Virol 2002;67:259-266.
18. Trotta M, Azzi A, Meli M, Borchi B, Periti E, Pontello V, Leoncini F: Intrauterine parvovirus B19 infection: early prenatal diagnosis is possible. Int J Infect Dis 2004;8:130-131.
19. Baschat AA, Towbin J, Bowles NE, Harman CR, Weiner CP: Prevalence of viral DNA in amniotic fluid of low-risk pregnancies in the second trimester. J Matern Fetal Neonatal Med 2003;13:381-384.
20. Heegaard ED, Brown KE: Human parvovirus B19. Clin Microbiol Rev 2002;15:485-505.
21. Rodis JF, Rodner C, Hansen AA, Borgida AF, Deoliveira I, Shulman RS: Long-term outcome of children following maternal human parvovirus B19 infection. Obstet Gynecol 1998;91:125-128.
22. Saldanha J, Lelie N, Yu MW, Heath A: B19 Collaborative Study Group. Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques. Vox Sang 2002;82:24-31.
23. Beersma MF, Claas EC, Sopaheluakan T, Kroes AC: Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples. J Clin Virol 2005;34:71-75.
24. Mari G: Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunisation. N Engl J Med 2000;342:9-14.
25. Cosmi E, Mari G, Delle Chiaie L, Detti L, Akiyama M, Murphy J, Stefos T, Ferguson JE 2nd, Hunter D, Hsu CD, Abuhamad A, Bahado-Singh R: Noninvasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection. Am J Obstet Gynecol 2002;187:1290-1293.
26. Enders M, Schalasta G, Baisch C, Weidner A, Pukkila L, Kaikkonen L, Lankinen H, Hedman L, Soderlund-Venermo M, Hedman K: Human parvovirus B19 infection during pregnancy - Value of modern molecular and serological diagnostics. J Clin Virol 2006;35:400-406.
27. Jordan JA, Huff D, DeLoia JA: Placental cellular immune response in women infected with human parvovirus B19 during pregnancy. Clin Diagn Lab Immunol 2001;8:288-292.
28. Reintjes R, Bosman A, Buitenwerf J: Parvovirus B19 infection in pregnancy: a cause of non-immune hydrops fetalis. Ned Tijdschr Geneeskd 1999;143:542.
29. Durandy A: Development of the immune system. Pathol Biol (Paris) 1992;40:685-689.
30. Zerbini M, Musiani M, Gentilomi G, Venturoli S, Gallinella G, Morandi R: Comparative evaluation of virological and serological methods in prenatal diagnosis of parvovirus B19 fetal hydrops. J Clin Microbiol 1996;34:603-608.
31. Wattre P, Dewilde A, Subtil D, Andreoletti L, Thirion V: A clinical and epidemiological study of human parvovirus B19 infection in fetal hydrops using PCR Southern blot hybridization and chemiluminescence detection. J Med Virol 1998;54:140-144.
32. van Gessel PH, Gaytant MA, Vossen AC, Galama JM, Ursem NT, Steegers EA, Wildschut HI: Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: A prospective study. Eur J Obstet Gynecol Reprod Biol 2006 [Epub ahead of print].